# A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain

> **NCT07377721** · PHASE1 · RECRUITING · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 168 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathic Pain

## Interventions

- **DRUG:** HRS-2129 Tablets
- **DRUG:** HRS-2129 Placebo
- **DRUG:** Pregabalin Capsules
- **DRUG:** Pregabalin Capsules Placebo

## Key facts

- **NCT ID:** NCT07377721
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-24
- **Primary completion:** 2026-09
- **Final completion:** 2026-11
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377721, "A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07377721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*